Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec treatment and glucose profile using instant scanning glucose monitoring in type 2 diabetes
ChiCTR2000034599Phase 4Recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoint: time in range. Started Jul 2020; status: recruiting.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000034599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034599.